Osaic Holdings’s Oncolytics Biotech ONCY Stock Holding History
Bought
Maintained
Sold
Other funds holding ONCY
XT
SI
IAIM
CCM
TAM
EFG
PI
Osaic Holdings's ONCY Position: Q2 2026 in Review
Osaic Holdings increased its Oncolytics Biotech (ONCY) stake by 140% in Q2 2026, buying an estimated $10.7K and bringing the position to 19,700 shares worth $18.7K. The position accounts for ﹤0.01% of the portfolio, ranked #6226.
Osaic Holdings first reported a position in ONCY in Q1 2020 and has held it in 26 quarters since. The position peaked at $286K in Q1 2023. 75 funds tracked by Wall St. Rank hold ONCY as of Q2 2026.
- Osaic Holdings held 19,700 shares of Oncolytics Biotech worth $18.7K as of Q2 2026.
- Osaic Holdings bought 11,500 Oncolytics Biotech shares in Q2 2026, an estimated $10.7K.
- Oncolytics Biotech made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #6226 holding.
- Osaic Holdings first reported a position in Oncolytics Biotech in Q1 2020 and has held it in 26 quarters since.
- Osaic Holdings's Oncolytics Biotech position peaked at $286K in Q1 2023.
- 75 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q2 2026.
Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.